Literature DB >> 19422808

Demethoxycurcumin induces Bcl-2 mediated G2/M arrest and apoptosis in human glioma U87 cells.

Pratibha Mehta Luthra1, Rakesh Kumar, Amresh Prakash.   

Abstract

Docking analysis of curcumin (C1), demethoxycurcumin (C2) and bisdemethoxycurcumin (C3) with Bcl-2 illustrated that among the three curcuminoids, C2 binds more efficiently into its putative active site. C1, C2 and C3 were purified from turmeric rhizomes to demonstrate the molecular mechanism of their anticancer activity on human glioma U87 cells. Human glioma U87 cells treated with curcuminoids resulted in activation of Bcl-2 mediated G2 checkpoint, which was associated with the induction of G2/M arrest and apoptosis. The binding of C1, C2 and C3 with Bcl-2 protein was confirmed with circular dichroism (CD) spectroscopy. Present work revealed that C2 induced Bcl-2 mediated G2/M arrest and apoptosis most effectively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19422808     DOI: 10.1016/j.bbrc.2009.04.149

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

1.  Demethoxycurcumin was prior to temozolomide on inhibiting proliferation and induced apoptosis of glioblastoma stem cells.

Authors:  Lei Shi; Xifeng Fei; Zhimin Wang
Journal:  Tumour Biol       Date:  2015-04-16

2.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

Review 3.  Neuroprotection by spice-derived nutraceuticals: you are what you eat!

Authors:  Ramaswamy Kannappan; Subash Chandra Gupta; Ji Hye Kim; Simone Reuter; Bharat Bhushan Aggarwal
Journal:  Mol Neurobiol       Date:  2011-03-01       Impact factor: 5.590

4.  Rapid separation and quantitation of curcuminoids combining pseudo two-dimensional liquid flash chromatography and NMR spectroscopy.

Authors:  G K Jayaprakasha; G A Nagana Gowda; Sixto Marquez; Bhimanagouda S Patil
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-08-16       Impact factor: 3.205

5.  Investigating the therapeutic role and molecular biology of curcumin as a treatment for glioblastoma.

Authors:  Gregor A Rodriguez; Ashish H Shah; Zachary C Gersey; Sumedh S Shah; Amade Bregy; Ricardo J Komotar; Regina M Graham
Journal:  Ther Adv Med Oncol       Date:  2016-04-25       Impact factor: 8.168

6.  Combined treatment of AT101 and demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cells.

Authors:  Moiken Mehner; Carolin Kubelt; Vivian Adamski; Christina Schmitt; Michael Synowitz; Janka Held-Feindt
Journal:  J Cancer Res Clin Oncol       Date:  2019-12-16       Impact factor: 4.553

Review 7.  Multitargeting by curcumin as revealed by molecular interaction studies.

Authors:  Subash C Gupta; Sahdeo Prasad; Ji Hye Kim; Sridevi Patchva; Lauren J Webb; Indira K Priyadarsini; Bharat B Aggarwal
Journal:  Nat Prod Rep       Date:  2011-10-06       Impact factor: 13.423

Review 8.  Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agents.

Authors:  Athanassios P Kyritsis; Melissa L Bondy; Victor A Levin
Journal:  Nutr Cancer       Date:  2011       Impact factor: 2.900

9.  Demethoxycurcumin was superior to temozolomide in the inhibition of the growth of glioblastoma stem cells in vivo.

Authors:  Liang Leng; Xiaojun Zhong; Guan Sun; Wen Qiu; Lei Shi
Journal:  Tumour Biol       Date:  2016-10-18

10.  Low-Dose DMC Significantly Enhances the Effect of TMZ on Glioma Cells by Targeting Multiple Signaling Pathways Both In Vivo and In Vitro.

Authors:  Lei Shi; Guan Sun
Journal:  Neuromolecular Med       Date:  2015-10-12       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.